AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27575034 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine with triamcinolone (steroids)
Number of subjects: 910
Study 27575034 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine without steroids (control)
Number of subjects: 910
Study 24549598 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte PIK3CD mRNA expression in GDM
Number of subjects: 175
Study 24549598 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte PIK3CD mRNA expression
Number of subjects: 175
Study 21562918 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified two-port VATS procedure (group A)
Number of subjects: 66
Study 21562918 — intervention group
Group type: COMPARATOR
Intervention: Axillary minithoracotomy (group B)
Number of subjects: 66
Study 20717085 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct machine parameter optimization (DMPO) plan
Number of subjects: 30
Study 20717085 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluence only (FO) plan
Number of subjects: 30
Study 20717085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative dose evaluation
Number of subjects: 30
Study 20717085 — intervention group
Group type: EXPERIMENTAL
Intervention: Average fractional dose
Number of subjects: 30
Study 20717085 — intervention group
Group type: EXPERIMENTAL
Intervention: CTV-to-PTV margins
Number of subjects: 30
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: DHASCO-T capsules at doses of 200 mg DHA per day
Number of subjects: 36
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: DHASCO-T capsules at doses of 600 mg DHA per day
Number of subjects: 36
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: DHASCO-T capsules at doses of 1,000 mg DHA per day
Number of subjects: 36
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: DHASCO-S capsules at doses of 200 mg DHA per day
Number of subjects: 36
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: DHASCO-S capsules at doses of 600 mg DHA per day
Number of subjects: 36
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: DHASCO-S capsules at doses of 1,000 mg DHA per day
Number of subjects: 36
Study 17713804 — intervention group
Group type: EXPERIMENTAL
Intervention: Algal-DHA-fortified food
Number of subjects: 36
Study 15842464 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral UFT
Number of subjects: 20
Study 15842464 — intervention group
Group type: COMPARATOR
Intervention: Bolus IV 5-FU
Number of subjects: 20
Study 12061758 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental simulation of lifting a heavy object
Number of subjects: 5
Study 12061758 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of simulation exercises
Number of subjects: 5
Study 12061758 — intervention group
Group type: EXPERIMENTAL
Intervention: Amount of weight simulated lifting
Number of subjects: 5
Study 12061758 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental simulations manipulated within subjects
Number of subjects: 5
Study 9657469 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 227
Study 9657469 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 227
Study 7808848 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms subunit vaccine
Number of subjects: 33
Study 7808848 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms subunit vaccine
Number of subjects: 33
Study 7808848 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo control
Number of subjects: 33
Study 2766267 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational preparation 1‐2 days prior to surgery
Number of subjects: 30
Study 2766267 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychoeducational preparation)
Number of subjects: 30
Study 1130885 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin or Cephalothin (antibiotic therapy randomized, given intravenously prior to operation and for 5 days thereafter)
Number of subjects: 512
Study 31918232 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐ or mixed‐gender group therapy (for women)
Number of subjects: 158
Study 31918232 — intervention group
Group type: COMPARATOR
Intervention: Mixed‐gender group therapy (for men)
Number of subjects: 158
Study 31918232 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress and substance use levels
Number of subjects: 158
Study 31918232 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress (controlling for substance use)
Number of subjects: 158
Study 31272977 — intervention group
Group type: EXPERIMENTAL
Intervention: AppSalt intervention group
Number of subjects: 1782
Study 31272977 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1782
Study 29018064 — intervention group
Group type: EXPERIMENTAL
Intervention: Melanoma Care Intervention (psychoeducational booklet, Cancer Council booklet, up to five telephone-based sessions with a psychologist)
Number of subjects: 24
Study 29018064 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Cancer Council booklet only)
Number of subjects: 24
Study 26202996 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment (cognitive-behavioral therapy)
Number of subjects: 151
Study 26202996 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 151
Study 23975656 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg
Number of subjects: 24
Study 23975656 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg
Number of subjects: 24
Study 21447531 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of gelatin microspheres prepared with basic fibroblast growth factor (b‐FGF)
Number of subjects: 42
Study 21447531 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment without any topical treatment
Number of subjects: 42
Study 19327625 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based nurse care (HBNC) for 12 months
Number of subjects: 96
Study 19327625 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based nurse care (HBNC) for 12 months in patients with supramedian BNP
Number of subjects: 96
Study 19327625 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study 16892912 — intervention group
Group type: COMPARATOR
Intervention: Vaccine
Number of subjects: 0
Study 16892912 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential and multistage designs
Number of subjects: 0
Study 15306668 — intervention group
Group type: EXPERIMENTAL
Intervention: Venom immunotherapy
Number of subjects: 1033
Study 15306668 — intervention group
Group type: COMPARATOR
Intervention: No venom immunotherapy
Number of subjects: 1033
Study 11879271 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased education for rural providers using clinical opinion leaders
Number of subjects: 0
Study 9251637 — intervention group
Group type: EXPERIMENTAL
Intervention: English-language articles reporting significant results (p < 0.05)
Number of subjects: 40
Study 9251637 — intervention group
Group type: COMPARATOR
Intervention: German-language articles reporting significant results (p < 0.05)
Number of subjects: 40
Study 9251637 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of significant results between English and German articles
Number of subjects: 40
Study 9251637 — intervention group
Group type: EXPERIMENTAL
Intervention: Publication odds for trials with significant results in English
Number of subjects: 40
Study 8505011 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal spray (11 mg natural progesterone)
Number of subjects: 20
Study 8505011 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injection (11 mg natural progesterone)
Number of subjects: 20
Study 3476985 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel followed by 1% NaF gel daily for 2 weeks
Number of subjects: 0
Study 3476985 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel followed by 1% NaF gel daily for 6 weeks supplemented twice with 8% SnF2 solution
Number of subjects: 0
Study 29715520 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid medications
Number of subjects: 34
Study 29715520 — intervention group
Group type: COMPARATOR
Intervention: Nonopioid medications
Number of subjects: 34
Study 27237059 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton irradiation
Number of subjects: 92
Study 27237059 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion irradiation
Number of subjects: 92
Study 27237059 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton and carbon ion irradiation
Number of subjects: 92
Study 25509731 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog-days moxibustion
Number of subjects: 72
Study 25509731 — intervention group
Group type: COMPARATOR
Intervention: Regular-day moxibustion
Number of subjects: 72
Study 25509731 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Dog-days and Regular-day moxibustion)
Number of subjects: 72
Study 22421490 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based microsurgical curriculum
Number of subjects: 17
Study 22421490 — intervention group
Group type: COMPARATOR
Intervention: Control group (no online resource)
Number of subjects: 17
Study 19968674 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender scent
Number of subjects: 340
Study 19968674 — intervention group
Group type: COMPARATOR
Intervention: No odor (Control)
Number of subjects: 340
Study 18701540 — intervention group
Group type: EXPERIMENTAL
Intervention: Static resting splints plus standardized occupational therapy
Number of subjects: 120
Study 18701540 — intervention group
Group type: COMPARATOR
Intervention: Standardized occupational therapy alone
Number of subjects: 120
Study 15808245 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium plaque brachytherapy (Sr90) using plaque I (8 mm diameter, 15 Gy dose in 54 minutes)
Number of subjects: 86
Study 15808245 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium plaque brachytherapy (Sr90) using plaque II (4 mm diameter, 12.6 Gy dose in 11 minutes)
Number of subjects: 86
Study 15808245 — intervention group
Group type: COMPARATOR
Intervention: Control group (observation without treatment)
Number of subjects: 86
Study 14650694 — intervention group
Group type: EXPERIMENTAL
Intervention: Equation instruction group
Number of subjects: 39
Study 14650694 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgoal instruction group
Number of subjects: 39
Study 14650694 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 10791612 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted health care program
Number of subjects: 0
Study 10791612 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8676527 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed micelles (bile-salt lecithin micelles)
Number of subjects: 12
Study 8676527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11188601 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder Pain and Disability Index (SPADI)
Number of subjects: 37
Study 6365467 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemetizide (25 mg) + Triamterene (50 mg)
Number of subjects: 0
Study 6365467 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide (0.25 mg) + Potassium Chloride (600 mg)
Number of subjects: 0
Study 30807430 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pain regimen
Number of subjects: 68
Study 27821627 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab with standard therapy
Number of subjects: 34
Study 27821627 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 34
Study 25817576 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with Defibrillator (CRT-D)
Number of subjects: 1250
Study 25817576 — intervention group
Group type: COMPARATOR
Intervention: Implantable Cardioverter-Defibrillator (ICD)
Number of subjects: 1250
Study 24506289 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg/day
Number of subjects: 0
Study 24506289 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg/day
Number of subjects: 0
Study 24506289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22382410 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical masking by spray-coating famotidine with ethyl cellulose
Number of subjects: 31
Study 22382410 — intervention group
Group type: EXPERIMENTAL
Intervention: Organoleptic masking with added sweetener and flavor
Number of subjects: 31
Study 22382410 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both taste-masking methods
Number of subjects: 31
Study 22382410 — intervention group
Group type: COMPARATOR
Intervention: Placebo ODTs
Number of subjects: 31
Study 19302453 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized pre-operative blood saving protocol (including strategies such as oral iron therapy, intravenous iron therapy, recombinant human erythropoietin alpha with i.v. iron, pre-operative autologous donation plus oral iron)
Number of subjects: 305
Study 19302453 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative autologous donation (PAD)
Number of subjects: 305
Study 19302453 — intervention group
Group type: COMPARATOR
Intervention: RBC transfusion
Number of subjects: 305
Study 17967591 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (50 mg or 75 mg tid for 1 week, then reduced to 25 mg or 50 mg tid)
Number of subjects: 201
Study 17967591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 17967591 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 201
Study 16335169 — intervention group
Group type: EXPERIMENTAL
Intervention: Crown-retained FPDs cemented with glass ionomer (n = 20) or resin composite (n = 16)
Number of subjects: 68
Study 16335169 — intervention group
Group type: COMPARATOR
Intervention: Inlay-retained FPDs cemented with resin composite (n = 45)
Number of subjects: 68
Study 12144231 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-generation gray Transitions Lenses
Number of subjects: 52
Study 12144231 — intervention group
Group type: COMPARATOR
Intervention: Clear lenses
Number of subjects: 52
Study 12144231 — intervention group
Group type: COMPARATOR
Intervention: Study purple-colored photochromic lens
Number of subjects: 52
Study 10445717 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipass technique
Number of subjects: 95
Study 10445717 — intervention group
Group type: COMPARATOR
Intervention: Single pass technique
Number of subjects: 95
Study 8526266 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program involving viewing videotaped scenes where knee injuries occurred
Number of subjects: 179
Study 8526266 — intervention group
Group type: COMPARATOR
Intervention: Control group (staff from 22 ski areas not exposed to the training)
Number of subjects: 179
Study 1969066 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate supplementation (50 mg per day)
Number of subjects: 0
Study 1969066 — intervention group
Group type: COMPARATOR
Intervention: Control group (no phosphate supplementation)
Number of subjects: 0
Study 154921 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide
Number of subjects: 22
Study 154921 — intervention group
Group type: COMPARATOR
Intervention: Flumethasone pivalate
Number of subjects: 22
Study 30399024 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (2000 IU/day)
Number of subjects: 703
Study 28218661 — intervention group
Group type: EXPERIMENTAL
Intervention: LZComplex3
Number of subjects: 171
Study 28218661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 25879974 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 2
Study 25879974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 23990341 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 120
Study 23990341 — intervention group
Group type: COMPARATOR
Intervention: Comparator (pooled intravenous standard therapies: semi-synthetic penicillin or vancomycin)
Number of subjects: 120
Study 23990341 — intervention group
Group type: COMPARATOR
Intervention: Semi-synthetic penicillin
Number of subjects: 120
Study 23990341 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 120
Study 21375959 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ultrasound (0.5 W/cm2) delivered at 1 MHz, pulsed pattern of 1:4, applied to periulcer skin weekly for up to 12 weeks alongside standard care.
Number of subjects: 337
Study 21375959 — intervention group
Group type: COMPARATOR
Intervention: Standard care (low‐adherent dressings and compression therapy).
Number of subjects: 337
Study 19926050 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 150 mg once daily for 1 week
Number of subjects: 40
Study 19926050 — intervention group
Group type: COMPARATOR
Intervention: Standard maintenance dosage clopidogrel (75 mg)
Number of subjects: 40
Study 17302062 — intervention group
Group type: EXPERIMENTAL
Intervention: Prunellae Oral Liquid (POL) based on classical therapy
Number of subjects: 98
Study 17302062 — intervention group
Group type: COMPARATOR
Intervention: Classical therapy alone
Number of subjects: 98
Study 17302062 — intervention group
Group type: COMPARATOR
Intervention: Normal control (20 healthy subjects)
Number of subjects: 98
Study 15566594 — intervention group
Group type: EXPERIMENTAL
Intervention: lornoxicam (8 mg administered intravenously every 12 hours for six doses)
Number of subjects: 40
Study 15566594 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 11879377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11879377 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing situation
Number of subjects: 0
Study 9928916 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (30 mg/day)
Number of subjects: 8
Study 9928916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8310990 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet (HFD)
Number of subjects: 8
Study 8310990 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber diet (LFD)
Number of subjects: 8
Study 2525023 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined reflex-therapy (including manipulations, neural therapy, and acupuncture)
Number of subjects: 1167
Study 2525023 — intervention group
Group type: COMPARATOR
Intervention: Usual ambulant medicamentous physiotherapeutic treatment
Number of subjects: 1167
Study 132779 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetasone 0.25% (Ibaril)
Number of subjects: 50
Study 132779 — intervention group
Group type: COMPARATOR
Intervention: Fluocinolone acetonide 0.025% cream
Number of subjects: 50
Study 31446845 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised cardiopulmonary bypass strategy (closed Cortiva® heparin‐coated circuit, low systemic heparinisation, intraoperative cell salvage)
Number of subjects: 60
Study 31446845 — intervention group
Group type: COMPARATOR
Intervention: Balance® coated open circuit, full systemic heparinisation, conventional cardiotomy suction (control group)
Number of subjects: 60
Study 30948692 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic Acid (5 mg/day)
Number of subjects: 36
Study 30948692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 27267689 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose beetroot juice (H-BT; 250 ml, n=10)
Number of subjects: 29
Study 27267689 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose beetroot juice (L-BT; 125 ml, n=9)
Number of subjects: 29
Study 27267689 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric placebo (PLA; 250 ml, n=10)
Number of subjects: 29
Study 25881059 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS-based intervention for treatment adherence
Number of subjects: 39
Study 24130255 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching Intervention (CI)
Number of subjects: 73
Study 24130255 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 73
Study 21957667 — intervention group
Group type: EXPERIMENTAL
Intervention: Salovum egg yolk powder plus standard treatment
Number of subjects: 40
Study 21957667 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 40
Study 19661012 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol XL 25 mg/chlorthalidone 6.25 mg
Number of subjects: 130
Study 19661012 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol XL 50 mg/chlorthalidone 12.5 mg
Number of subjects: 130
Study 19661012 — intervention group
Group type: COMPARATOR
Intervention: metoprolol XL 25 mg/HCTZ 12.5 mg
Number of subjects: 130
Study 19661012 — intervention group
Group type: COMPARATOR
Intervention: metoprolol XL 50 mg/HCTZ 12.5 mg
Number of subjects: 130
Study 16935462 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment
Number of subjects: 42
Study 16935462 — intervention group
Group type: COMPARATOR
Intervention: Control group (no L-thyroxine treatment)
Number of subjects: 42
Study 14632164 — intervention group
Group type: EXPERIMENTAL
Intervention: TG‐timolol
Number of subjects: 14
Study 14632164 — intervention group
Group type: COMPARATOR
Intervention: timolol only
Number of subjects: 14
Study 10711416 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate therapy
Number of subjects: 28
Study 10711416 — intervention group
Group type: COMPARATOR
Intervention: Dietary modification alone (Placebo)
Number of subjects: 28
Study 10711416 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 9176179 — intervention group
Group type: EXPERIMENTAL
Intervention: GH + placebo
Number of subjects: 8
Study 9176179 — intervention group
Group type: EXPERIMENTAL
Intervention: GH + captopril
Number of subjects: 8
Study 9176179 — intervention group
Group type: EXPERIMENTAL
Intervention: GH + spironolactone
Number of subjects: 8
Study 9176179 — intervention group
Group type: COMPARATOR
Intervention: Placebo + placebo
Number of subjects: 8
Study 1390955 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol or perazine (neuroleptic drugs)
Number of subjects: 59
Study 1390955 — intervention group
Group type: EXPERIMENTAL
Intervention: Involuntary expression under emotion-eliciting interview conditions
Number of subjects: 59
Study 1390955 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary expression
Number of subjects: 59